OA03.08 Activity of Ensartinib after Second Generation Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors (TKI): Topic: Medical Oncology
暂无分享,去创建一个
H. Wakelee | C. Liang | L. Gandhi | G. Oxnard | J. Gockerman | L. Horn | A. Chiappori | K. Reckamp | G. Blumenschein | S. Waqar | G. Dukart | K. Harrow | T. Leal | F. Tan